Generic Name

[Antihemophilic Factor (Recombinant)]

Manufacturer

Takeda

Indications

RECOMBINATE is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes and for the perioperative management of patients with hemophilia A. RECOMBINATE is not indicated for von Willebrand’s disease.

Product Options

Vial Size

NDC #

Manufacturer #

Size

220-400 IU

0944-2831-10

501592

10ml w/ Baxjet II Device

401-800 IU

0944-2832-10

1501593

10ml w/ Baxjet II Device

801-1240 IU

0944-2833-10

1501594

10ml w/ Baxjet II Device

1241-1800 IU

0944-2834-10

1502946

10ml w/ Baxjet II Device

1801-2400 IU

0944-2835-10

1502947

10ml w/ Baxjet II Device

220-400 IU

0944-2841-10

1502735

5ml w/ Baxjet II Device

401-800 IU

0944-2842-10

1502736

5ml w/ Baxjet II Device

801-1240 IU

0944-2843-10

1502737

5ml w/ Baxjet II Device

1241-1800 IU

0944-2844-10

1503132

5ml w/ Baxjet II Devic

1801-2400 IU

0944-2845-10

1503133

5ml w/ Baxjet II Device

Shelf Life and Storage

36 Months / Refrigeration 2° – 8°C (36° – 46°F) or room temperature, not to exceed 30°C or 86°F until expiration date noted on package.